Work

Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research

Year: 2020

Type: review

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(20)30107-8

Authors: Douglas B Johnson, Kerry L Reynolds, Ryan J Sullivan, Justin M Balko, James R Patrinely, Laura C Cappelli, Jarushka Naidoo, Javid J Moslehi

Institutions: Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Massachusetts General Hospital, Vanderbilt University, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Melanoma Research Foundation, National Institutes of Health, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: Predicting and profiling long-term survival after immune checkpoint inhibition, G5545333139, (PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition, Understanding Inflammatory Arthritis due to Immune Checkpoint Inhibitors

OpenAlex ID: W3047192227

FWCI: 2.068

Cites: 61

Cited by: 118

Related to: 10